Preoperative use of recombinant human erythropoietin before total joint arthroplasty

Journal of Bone and Joint Surgery

Volumn 85, Issue 9, 2003, Pages 1795-1800

  Bezwada, Hari P ^a   Nazarian, David G ^a   Henry, David H ^a   Booth, Robert P ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTHROPLASTY; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CONSTIPATION; FEMALE; FEVER; HEART ATRIUM FIBRILLATION; HEMATOLOGICAL PARAMETERS; HEMATOMA; HEMOGLOBIN DETERMINATION; HUMAN; INJECTION SITE; JOINT PROSTHESIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NAUSEA; OSTEOARTHRITIS; PERIOPERATIVE PERIOD; PERONEUS NERVE PARALYSIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SKIN IRRITATION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

EID: 0141521847     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200309000-00020     Document Type: Article

References (31)

1. Lotke PA, Faralii VJ, Orensteln EM, Ecker ML. Blood loss after total knee replacement. Effects of tourniquet release and continuous passive motion. J Bone Joint Surg Am. 1991;73:1037-40.
2. Kanter MH, van Maanen D, Anders KH, Castro F, Mya WW, Clark K. Preoperative autologous blood donations before elective hysterectomy. JAMA. 1996;276:798-801.
3. Goldman M, Remy-Prince S, Trepanler A, Decary F. Autologous donation error rates in Canada. Transfusion. 1997;37:523-7.
4. Richards C, Kolins J. Trindade CD. Autologous transfusion-transmitted Yersinia enterocolitica. JAMA. 1992;268:1541-2.
5. Sire JM, Michelet C, Mesnard R, Tardivel R, Minet J, Bracq H, Avril JL. Septic shock due to Yersinia enterocolitica after autologous transfusion. Clin Infect Dis. 1993;17:954-5.
6. Pink J, Thomson A, Wylle B. Infectious disease markers in autologous and directed donations. Transfus Med. 1994;4:135-8.
7. Kanter MH, Petz L, The validity of statistical analyses in the transfusion medicine literature with specific comments concerning studies of the comparative safety of units donated by autologous, designated, and allogeneic donors. Transfus Med. 1995;5:91-5.
8. Whyte F, Coghlan P. Comparative safety of units donated by autologous, designated, and allogeneic (homologous) donors. Transfus Med. 1996;6:209-11.
9. Farls PM, Ritter MA, Abels RI. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am. 1996;78:62-72.
10. Goldberg MA, McCutchen JW, Jove M, DI Cesare P, Frledman RJ, Poss R, Gullfoyle M, Frel D, Young D. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop. 1996;25:544-52.
11. Rutherford CJ, Schneider TJ, Dempsey H, Kirn DH, Brugnara C, Goldberg MA. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response. Am J Med. 1994;96:139-45.
12. de Andrade JR, Jove M, Landon G, Frei D, Gullfoyle M, Young DC. Baseline hemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients. Am J Orthop. 1996;25:533-42.
13. Matsuda S, Kondo M, Mashima T, Hoshino S. Shinohara N, Sumida S. Recombinant human erythropoietin therapy for autologous blood donation in rheumatoid arthritis patients undergoing total hip or knee arthroplasty. Orthopedics. 2001;24:41-4.
14. Faris P. Use of recombinant human erythropoietin in the perioperative period of orthopedic surgery. Am J Med. 1996;101:28S-32S.
15. Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet. 1993;341:1227-32.
16. Stowell CP, Chandler H, Jove M, Gullfoyle M, Wacholtz MC. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty. Orthopedics. 1999;22(1 Suppl):S105-12.
17. de Andrade JR, Frel D, Gullfoyle M. Integrated analysis of thrombotic/vascular event occurrence in epoetin alfa-treated patients undergoing major, elective orthopedic surgery. Orthopedics. 1999;22(1 Suppl):S113-8.
18. Lemos MJ, Healy WL. Blood transfusion in orthopaedic operations. J Bone Joint Surg Am. 1996;78:1260-70.
19. Monk TG, Goodnough LT. Acute normovolemic hemodilution. Clin Orthop. 1998;357:74-81.
20. Ness PM, Bourke DL, Walsh PC. A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery. Transfusion. 1992;32:226-30.
21. Healy WL, Pfeifer BA, Kurtz SR, Johnson C, Johnson W, Johnston R, Sanders D, Karpman R, Hallack GN, Valerl CR. Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop. 1994;299:53-9.
22. Wilson WJ, Intraoperative autologous transfusion in revision total hip arthroplasty. J Bone Joint Surg Am. 1989;71:8-14.
23. Clements DH, Sculco TP, Burke SW, Mayer K, Levine DB. Salvage and reinfusion of postoperative sanguineous wound drainage. A preliminary report. J Bone Joint Surg Am. 1992;74:646-51.
24. Goodnough LT, Anderson KC, Kurtz S, Lane TA, Pisclotto PT, Sayers MH, Silberstein LE. Indications and guidelines for the use of hematopoietic growth factors. Transfusion. 1993;33:944-59.
25. Goodnough LT, Rudnick S, Price TH, Ballas SK, Collins ML, Crowley JP, Kosmin M, Kruskall MS, Lenes BA, Menitove JE, Silberstein LE, Smith KJ, Wallas CH, Abels R, Von Tress M. Increased preoperative collection of autoogous blood with recombinant human erythropoietin therapy. N Engl J Med. 1989;321:1163-8.
26. Blerbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999;81:2-10.
27. Billote DB, Glisson SN, Green D, Wixson RL. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am. 2002;84:1299-304.
28. Thomson JD, Callaghan JJ, Savory CG, Stanton RP, Pierce RN. Prior deposition of autologous blood in elective orthopaedic surgery. J Bone Joint Surg Am. 1987;69:320-4.
29. Lotke PA, Barth P, Garino JP, Cook EF. Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration. J Arthroplasty. 1999;14:647-50.
30. Woolson ST, Marsh JS, Tanner JB. Transfusion of previously deposited autologous blood for patients undergoing hip-replacement surgery. J Bone Joint Surg Am. 1987;69:325-8.
31. Toy PT, Kaplan EB, McVay PA, Lee SJ, Strauss RG, Stehling LC. Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study Group. Transfusion. 1992;32:63-7.